Literature DB >> 19108140

The anatomical basis of the straub phenomenon.

D L Bilbey, H Salem, M H Grossman.   

Abstract

The administration of morphine was followed in white mice by a typical Straub reaction which consisted of the tail becoming rigid and erected across the back of the animal in an S-shaped curve. This reaction was accompanied by restlessness, excitability, extension rigidity of the hindlimbs, forcible viodance of faeces and prominence of the perineum. The Straub reaction was abolished by general anaesthesia with pentobarbitone or ether, by administration of tubocurarine, by bilateral section of the muscles causing extension to the tail, and by the removal of the circulation to the lower extremity. The reaction was modified by unilateral section of the extensor muscles of the tail. Section of the spinal cord, decortication, division of the anal sphincter and perineal floor, or ablation of the pelvic splanchnic nerves did not suppress the appearance of the Straub response. It was concluded that the phenomenon described by Straub (1911) was produced mainly by the action of the sacro-coccygeus dorsalis muscle, and that it was also necessary that the lumbo-sacral cord with its peripheral nervous outflow should be intact and that these functioning units should have an adequate circulation.

Entities:  

Year:  1960        PMID: 19108140      PMCID: PMC1482265          DOI: 10.1111/j.1476-5381.1960.tb00277.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  19 in total

1.  [D-Pen2, D-Pen5]enkephalin, the standard delta opioid agonist, induces morphine-like behaviors in mice.

Authors:  C W Murray; A Cowan
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  P-glycoprotein is a major determinant of norbuprenorphine brain exposure and antinociception.

Authors:  Sarah M Brown; Scott D Campbell; Amanda Crafford; Karen J Regina; Michael J Holtzman; Evan D Kharasch
Journal:  J Pharmacol Exp Ther       Date:  2012-06-27       Impact factor: 4.030

3.  An alcohol withdrawal test battery measuring multiple behavioral symptoms in mice.

Authors:  Pamela Metten; Jason P Schlumbohm; Lawrence C Huang; Gian D Greenberg; Wyatt R Hack; Stephanie E Spence; John C Crabbe
Journal:  Alcohol       Date:  2017-09-06       Impact factor: 2.405

4.  Protection against acetaldehyde toxicity in the rat by L-cysteine, thiamin and L-2-methylthiazolidine-4-carboxylic acid.

Authors:  H Sprince; C M Parker; G G Smith; L J Gonzales
Journal:  Agents Actions       Date:  1974-04

5.  Naloxone-reversible analgesic action of SKF 525-A in mice.

Authors:  T Lehman; G R Peterson
Journal:  Psychopharmacology (Berl)       Date:  1978-12-08       Impact factor: 4.530

6.  Antagonism of the morphine-induced Straub tail reaction by kappa-opioid receptor activation in mice.

Authors:  M Narita; T Suzuki; M Misawa; H Nagase
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Straub tail reaction in mice treated with σ(1) receptor antagonist in combination with methamphetamine.

Authors:  Junichi Kitanaka; Nobue Kitanaka; F Scott Hall; George R Uhl; Koh-Ichi Tanaka; Nobuyoshi Nishiyama; Motohiko Takemura
Journal:  Brain Res       Date:  2012-09-08       Impact factor: 3.252

8.  RHEB1 insufficiency in aged male mice is associated with stress-induced seizures.

Authors:  Qi Tian; Pavel Gromov; Joachim H Clement; Yingming Wang; Marc Riemann; Falk Weih; Xiao-Xin Sun; Mu-Shui Dai; Lev M Fedorov
Journal:  Geroscience       Date:  2017-09-10       Impact factor: 7.713

9.  Skin β-endorphin mediates addiction to UV light.

Authors:  Gillian L Fell; Kathleen C Robinson; Jianren Mao; Clifford J Woolf; David E Fisher
Journal:  Cell       Date:  2014-06-19       Impact factor: 41.582

10.  Pavlovian conditioning of multiple opioid-like responses in mice.

Authors:  Camron D Bryant; Kristofer W Roberts; Christopher S Culbertson; Alan Le; Christopher J Evans; Michael S Fanselow
Journal:  Drug Alcohol Depend       Date:  2009-05-05       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.